NCT03602612
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Explore clinical trials studying Myeloma, Plasma-Cell. Study availability and eligibility vary by location and protocol.
NCT03602612
NCT04065789
NCT03958656
NCT00421525
NCT02215967
NCT00600353
NCT00146055